Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes

Relation of Atrial and/or Ventricular Premature Complexes on a Two-Minute Rhythm Strip to the Risk of Sudden Cardiac Death (the Atherosclerosis Risk in Communities [ARIC] Study)

(2011) Pramil Cheriyath et al.   AMERICAN JOURNAL OF CARDIOLOGY

Low serum magnesium concentrations predict cardiovascular and all-cause mortality

(2011) Thorsten Reffelmann et al.   ATHEROSCLEROSIS

Does the prophylactic administration of magnesium sulphate to patients undergoing thoracotomy prevent postoperative supraventricular arrhythmias? A randomized controlled trial

(2011) T. Saran et al.   BRITISH JOURNAL OF ANAESTHESIA

A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum Calcium, -magnesium and -phosphate in Type 2 diabetes and non-diabetes metabolism

(2011) Lena Håglin et al.   Cardiovascular Diabetology

Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study

(2011) Jo Røislien et al.   Cardiovascular Diabetology

Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study

(2010) James M. Peacock et al.   AMERICAN HEART JOURNAL

Association of Holter-based measures including T-wave alternans with risk of sudden cardiac death in the community-dwelling elderly: the Cardiovascular Health Study

(2010) Phyllis K. Stein et al.   JOURNAL OF ELECTROCARDIOLOGY

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome

(2009) David Simmons et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Dietary n−6 and n−3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular prevention

(2008) Gian Luigi Russo   BIOCHEMICAL PHARMACOLOGY